387 related articles for article (PubMed ID: 23644382)
21. RhoA as a mediator of clinically relevant androgen action in prostate cancer cells.
Schmidt LJ; Duncan K; Yadav N; Regan KM; Verone AR; Lohse CM; Pop EA; Attwood K; Wilding G; Mohler JL; Sebo TJ; Tindall DJ; Heemers HV
Mol Endocrinol; 2012 May; 26(5):716-35. PubMed ID: 22456196
[TBL] [Abstract][Full Text] [Related]
22. lncRNA CTBP1-AS2 promotes proliferation and migration of glioma by modulating miR-370-3p-Wnt7a-mediated epithelial-mesenchymal transition.
Li Y; Zong J; Zhao C
Biochem Cell Biol; 2020 Dec; 98(6):661-668. PubMed ID: 33150795
[TBL] [Abstract][Full Text] [Related]
23. Novel lncRNA
Lingadahalli S; Jadhao S; Sung YY; Chen M; Hu L; Chen X; Cheung E
Mol Cancer Res; 2018 Dec; 16(12):1865-1878. PubMed ID: 30115758
[TBL] [Abstract][Full Text] [Related]
24. RNA-binding protein Musashi2 stabilizing androgen receptor drives prostate cancer progression.
Zhao J; Zhang Y; Liu XS; Zhu FM; Xie F; Jiang CY; Zhang ZY; Gao YL; Wang YC; Li B; Xia SJ; Han BM
Cancer Sci; 2020 Feb; 111(2):369-382. PubMed ID: 31833612
[TBL] [Abstract][Full Text] [Related]
25. Targeting Epigenetic and Posttranscriptional Gene Regulation by PSF Impairs Hormone Therapy-Refractory Cancer Growth.
Takayama KI; Honma T; Suzuki T; Kondoh Y; Osada H; Suzuki Y; Yoshida M; Inoue S
Cancer Res; 2021 Jul; 81(13):3495-3508. PubMed ID: 33975881
[TBL] [Abstract][Full Text] [Related]
26. The tumor suppressor ING1b is a novel corepressor for the androgen receptor and induces cellular senescence in prostate cancer cells.
Esmaeili M; Jennek S; Ludwig S; Klitzsch A; Kraft F; Melle C; Baniahmad A
J Mol Cell Biol; 2016 Jun; 8(3):207-20. PubMed ID: 26993046
[TBL] [Abstract][Full Text] [Related]
27. Long non-coding RNA FAM66C is associated with clinical progression and promotes cell proliferation by inhibiting proteasome pathway in prostate cancer.
Xie Y; Gu J; Qin Z; Ren Z; Wang Y; Shi H; Chen B
Cell Biochem Funct; 2020 Dec; 38(8):1006-1016. PubMed ID: 32430927
[TBL] [Abstract][Full Text] [Related]
28. Androgen receptor splice variants activate androgen receptor target genes and support aberrant prostate cancer cell growth independent of canonical androgen receptor nuclear localization signal.
Chan SC; Li Y; Dehm SM
J Biol Chem; 2012 Jun; 287(23):19736-49. PubMed ID: 22532567
[TBL] [Abstract][Full Text] [Related]
29. Oncogenic non-coding RNA NEAT1 promotes the prostate cancer cell growth through the SRC3/IGF1R/AKT pathway.
Xiong W; Huang C; Deng H; Jian C; Zen C; Ye K; Zhong Z; Zhao X; Zhu L
Int J Biochem Cell Biol; 2018 Jan; 94():125-132. PubMed ID: 29225160
[TBL] [Abstract][Full Text] [Related]
30. lncRNA-dependent mechanisms of androgen-receptor-regulated gene activation programs.
Yang L; Lin C; Jin C; Yang JC; Tanasa B; Li W; Merkurjev D; Ohgi KA; Meng D; Zhang J; Evans CP; Rosenfeld MG
Nature; 2013 Aug; 500(7464):598-602. PubMed ID: 23945587
[TBL] [Abstract][Full Text] [Related]
31. Succinylation of CTBP1 mediated by KAT2A suppresses its inhibitory activity on the transcription of CDH1 to promote the progression of prostate cancer.
Zhou J; Yan X; Liu Y; Yang J
Biochem Biophys Res Commun; 2023 Apr; 650():9-16. PubMed ID: 36764210
[TBL] [Abstract][Full Text] [Related]
32. Analysis of the androgen receptor-regulated lncRNA landscape identifies a role for ARLNC1 in prostate cancer progression.
Zhang Y; Pitchiaya S; Cieślik M; Niknafs YS; Tien JC; Hosono Y; Iyer MK; Yazdani S; Subramaniam S; Shukla SK; Jiang X; Wang L; Liu TY; Uhl M; Gawronski AR; Qiao Y; Xiao L; Dhanasekaran SM; Juckette KM; Kunju LP; Cao X; Patel U; Batish M; Shukla GC; Paulsen MT; Ljungman M; Jiang H; Mehra R; Backofen R; Sahinalp CS; Freier SM; Watt AT; Guo S; Wei JT; Feng FY; Malik R; Chinnaiyan AM
Nat Genet; 2018 Jun; 50(6):814-824. PubMed ID: 29808028
[TBL] [Abstract][Full Text] [Related]
33. Ligand-dependent corepressor acts as a novel androgen receptor corepressor, inhibits prostate cancer growth, and is functionally inactivated by the Src protein kinase.
Asim M; Hafeez BB; Siddiqui IA; Gerlach C; Patz M; Mukhtar H; Baniahmad A
J Biol Chem; 2011 Oct; 286(43):37108-17. PubMed ID: 21856747
[TBL] [Abstract][Full Text] [Related]
34. Role of the PLDLS-binding cleft region of CtBP1 in recruitment of core and auxiliary components of the corepressor complex.
Kuppuswamy M; Vijayalingam S; Zhao LJ; Zhou Y; Subramanian T; Ryerse J; Chinnadurai G
Mol Cell Biol; 2008 Jan; 28(1):269-81. PubMed ID: 17967884
[TBL] [Abstract][Full Text] [Related]
35. A novel long non-coding RNA PCLN16 facilitates androgen receptor signaling in prostate cancer.
Shi Z; Chen J; Wumaner A; Li M; Liang C; Li M
Biochem Biophys Res Commun; 2021 Jan; 537():78-84. PubMed ID: 33387886
[TBL] [Abstract][Full Text] [Related]
36. Expression of CtBP family protein isoforms in breast cancer and their role in chemoresistance.
Birts CN; Harding R; Soosaipillai G; Halder T; Azim-Araghi A; Darley M; Cutress RI; Bateman AC; Blaydes JP
Biol Cell; 2010 Jan; 103(1):1-19. PubMed ID: 20964627
[TBL] [Abstract][Full Text] [Related]
37. miR-34a Regulates Expression of the Stathmin-1 Oncoprotein and Prostate Cancer Progression.
Chakravarthi BVSK; Chandrashekar DS; Agarwal S; Balasubramanya SAH; Pathi SS; Goswami MT; Jing X; Wang R; Mehra R; Asangani IA; Chinnaiyan AM; Manne U; Sonpavde G; Netto GJ; Gordetsky J; Varambally S
Mol Cancer Res; 2018 Jul; 16(7):1125-1137. PubMed ID: 29025958
[TBL] [Abstract][Full Text] [Related]
38. The miR-644a/CTBP1/p53 axis suppresses drug resistance by simultaneous inhibition of cell survival and epithelial-mesenchymal transition in breast cancer.
Raza U; Saatci Ö; Uhlmann S; Ansari SA; Eyüpoğlu E; Yurdusev E; Mutlu M; Ersan PG; Altundağ MK; Zhang JD; Doğan HT; Güler G; Şahin Ö
Oncotarget; 2016 Aug; 7(31):49859-49877. PubMed ID: 27409664
[TBL] [Abstract][Full Text] [Related]
39. Zyflamend, a combination of herbal extracts, attenuates tumor growth in murine xenograft models of prostate cancer.
Huang EC; McEntee MF; Whelan J
Nutr Cancer; 2012; 64(5):749-60. PubMed ID: 22663543
[TBL] [Abstract][Full Text] [Related]
40. A feed-forward regulatory loop between androgen receptor and PlncRNA-1 promotes prostate cancer progression.
Fang Z; Xu C; Li Y; Cai X; Ren S; Liu H; Wang Y; Wang F; Chen R; Qu M; Wang Y; Zhu Y; Zhang W; Shi X; Yao J; Gao X; Hou J; Xu C; Sun Y
Cancer Lett; 2016 Apr; 374(1):62-74. PubMed ID: 26808578
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
